Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion type Assertion NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_head.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion description "[We investigated the prognostic relevance of IKZF1 deletions in 118 adult Ph-positive ALL patients who had minimal residual disease (MRD) data under a uniform treatment of allo-SCT following first-line imatinib-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_provenance.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion evidence source_evidence_literature NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_provenance.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion SIO_000772 25501350 NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_provenance.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion wasDerivedFrom befree-2016 NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_provenance.
- NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_assertion wasGeneratedBy ECO_0000203 NP1247567.RACJ9eaSJA-lIa1o9qPgfU9C8SM-wQJaVgq_bYGt_nlGM130_provenance.